15.02.2014 20:21:21

Biogen Idec Chairman William Young To Retire - Quick Facts

(RTTNews) - Biogen Idec (BIIB) Saturday announced that Chairman of the Board William (Bill) Young will retire from the company's Board, effective at the 2014 annual meeting of stockholders. Young has been a member of Biogen Idec's Board since 1997 and has served as Chairman since 2010.

Stelios Papadopoulos, a member of Biogen Idec's Board since 2008, has been appointed to assume the role of Chairman following the end of Young's term.

Papadopoulos is the former Vice Chairman of Cowen & Co. LLC and is the current Chairman of the Board at Exelixis Inc., a drug discovery company that he cofounded in 1994, and at Regulus Therapeutics Inc. Papadopoulos is also currently a member of the Board of Directors of BG Medicine Inc.

Analysen zu Biogen Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Biogen Inc 142,65 -0,45% Biogen Inc